MX2021014674A - Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. - Google Patents
Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.Info
- Publication number
- MX2021014674A MX2021014674A MX2021014674A MX2021014674A MX2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A MX 2021014674 A MX2021014674 A MX 2021014674A
- Authority
- MX
- Mexico
- Prior art keywords
- pyridine
- pyrazolo
- protein kinase
- kinase inhibitors
- substituted pyrrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se proporcionan ciertos inhibidores de BTK, sus composiciones farmacéuticas, y métodos de uso de los mismos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962854983P | 2019-05-31 | 2019-05-31 | |
US201962904611P | 2019-09-23 | 2019-09-23 | |
US201962935091P | 2019-11-14 | 2019-11-14 | |
PCT/CN2020/093734 WO2020239124A1 (en) | 2019-05-31 | 2020-06-01 | SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014674A true MX2021014674A (es) | 2022-01-11 |
Family
ID=73553523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014674A MX2021014674A (es) | 2019-05-31 | 2020-06-01 | Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220235049A1 (es) |
EP (1) | EP3976607A4 (es) |
JP (1) | JP2022534715A (es) |
KR (1) | KR20220016090A (es) |
CN (1) | CN114008042B (es) |
AU (1) | AU2020283597A1 (es) |
BR (1) | BR112021023607A2 (es) |
CA (1) | CA3137985A1 (es) |
MX (1) | MX2021014674A (es) |
WO (1) | WO2020239124A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230110286A (ko) * | 2020-11-17 | 2023-07-21 | 포천 바이오사이언시스, 리미티드 | 단백질 키나제 억제제로서 치환된 피롤로 [2,3-b] 피리딘 및 피라졸로 [3,4-b] 피리딘 유도체 |
EP4234558A1 (en) * | 2020-12-07 | 2023-08-30 | Zhejiang Longcharm Bio-Tech Pharma. Co., Ltd. | Pyrrolopyridine compound and application thereof |
CN112574200B (zh) * | 2021-02-26 | 2021-06-11 | 安润医药科技(苏州)有限公司 | Btk和/或btk的突变体c481s的小分子抑制剂 |
CN115028633B (zh) * | 2021-03-08 | 2023-12-22 | 药雅科技(上海)有限公司 | 吡咯并嘧啶类化合物的制备及其应用 |
CN113979891A (zh) * | 2021-11-08 | 2022-01-28 | 上海高准医药有限公司 | 一种克立硼罗及其中间产物的制备方法 |
WO2023110970A1 (en) | 2021-12-14 | 2023-06-22 | Netherlands Translational Research Center Holding B.V | Macrocyclic btk inhibitors |
CN114409654A (zh) * | 2021-12-30 | 2022-04-29 | 安徽普利药业有限公司 | 一种btk抑制剂的中间体合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1696920E (pt) * | 2003-12-19 | 2015-01-14 | Plexxikon Inc | Compostos e métodos para o desenvolvimento de moduladores de ret |
MY153898A (en) * | 2005-06-22 | 2015-04-15 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
AU2010321883A1 (en) * | 2009-11-18 | 2012-05-31 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
BR112015028845A2 (pt) * | 2013-05-30 | 2017-07-25 | Plexxikon Inc | compostos para a modulação da quinase e indicações da mesma |
WO2018039310A1 (en) * | 2016-08-24 | 2018-03-01 | Arqule, Inc. | Amino-pyrrolopyrimidinone compounds and methods of use thereof |
EP3823968A1 (en) * | 2018-07-16 | 2021-05-26 | HepaRegeniX GmbH | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
CN112608318B (zh) * | 2019-12-16 | 2023-09-08 | 成都海博为药业有限公司 | 一种作为蛋白质激酶抑制剂的化合物及其用途 |
-
2020
- 2020-06-01 WO PCT/CN2020/093734 patent/WO2020239124A1/en unknown
- 2020-06-01 BR BR112021023607A patent/BR112021023607A2/pt unknown
- 2020-06-01 MX MX2021014674A patent/MX2021014674A/es unknown
- 2020-06-01 AU AU2020283597A patent/AU2020283597A1/en active Pending
- 2020-06-01 JP JP2021570188A patent/JP2022534715A/ja active Pending
- 2020-06-01 US US17/615,420 patent/US20220235049A1/en active Pending
- 2020-06-01 EP EP20814173.9A patent/EP3976607A4/en active Pending
- 2020-06-01 KR KR1020217039485A patent/KR20220016090A/ko unknown
- 2020-06-01 CA CA3137985A patent/CA3137985A1/en active Pending
- 2020-06-01 CN CN202080040076.0A patent/CN114008042B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
EP3976607A1 (en) | 2022-04-06 |
KR20220016090A (ko) | 2022-02-08 |
CN114008042A (zh) | 2022-02-01 |
AU2020283597A1 (en) | 2021-11-25 |
BR112021023607A2 (pt) | 2022-01-04 |
CA3137985A1 (en) | 2020-12-03 |
US20220235049A1 (en) | 2022-07-28 |
EP3976607A4 (en) | 2023-07-19 |
WO2020239124A1 (en) | 2020-12-03 |
CN114008042B (zh) | 2023-10-03 |
JP2022534715A (ja) | 2022-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021014674A (es) | Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. | |
IL281127A (en) | Pyrazolo[3,4-B]pyridine compounds as inhibitors of TAM and MET kinases | |
PH12019500776A1 (en) | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | |
MY196474A (en) | [1,2,4]Triazolo[1,5-A]Pyridinyl Substituted Indole Compounds | |
CL2016002836A1 (es) | Compuestos derivados de pirido pirimidin con actividad moduladora del empalme genico de smn2; composicion farmaceutica y uso en el tratamiento de la atrofia muscular espinal (ame). | |
EP3749293A4 (en) | 2,3,4,5-TETRAHYDRO-1H-PYRIDO [4,3-B] INDOLES INHIBITORS OF CGAS USED FOR THE TREATMENT OF SELF-INFLAMMATORY DISEASES | |
WO2017108723A3 (en) | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | |
NZ744349A (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors | |
MX2020009586A (es) | Compuestos de (2-azabiciclo[3.1.0]hexan-2-il)pirazolo[1,5-a]pirimi dina e imidazo[1,2-b]piridazina sustituidos como inhibidores de cinasas trk. | |
SG11201907095UA (en) | DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
MX2017013874A (es) | Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa. | |
NZ703111A (en) | Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases | |
SG10201807952PA (en) | Jak1 inhibitors for the treatment of myelodysplastic syndromes | |
MX2019007073A (es) | Inhibidores de moléculas pequeñas de la familia de quinasas jak. | |
EP3515914A4 (en) | NEW IMIDAZO [1,5-A] PYRIDINES SUBSTITUTED IN POSITION 5 OR 8 AS INDOLEAMINE AND / OR TRYPTOPHANE 2,3-DIOXYGENASES | |
UY37559A (es) | Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton | |
NZ751284A (en) | Novel jak1 selective inhibitors and uses thereof | |
TN2018000078A1 (en) | 8-[6-[3-(amino)propoxy]-3-pyridyl]-1 -isopropyl-imidazo[4,5-c]quinolin-2-one derivatives as selective modulators of ataxia telangiectasia mutated (atm) kinase for the treatment of cancer | |
IL281924A (en) | Forms of pyrido[2,1-A]pyrimidin-4-one derivatives, their formulations and process for their preparation | |
EP4072548A4 (en) | COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZINE-1-YL)PYRAZOLO[ 1,5-A]PYRIMIDINE ANALOGUES AS INHIBITORS BY KRAS | |
MX2018002916A (es) | Metodos, composiciones y usos de nuevos inhibidores de fyn quinasa. | |
MX2019004070A (es) | Sistema de extraccion de un sistema de circuito cerrado. | |
MX2020010116A (es) | Compuestos macrociclicos como inhibidores de quinasas del receptor de tropomiosina (trk). | |
MX2017013886A (es) | Azabenzimidazoles y su uso como moduladores del receptor ampa. | |
PH12019501324A1 (en) | Pyrazolo[3,4-b]pyridines and imidazo [1,5-b] pyridazines as pde1 inhibitors |